Under CEO Kevin Hykes, Relievant Medsystems is racking up some wins. The company closed on a $58 million Series E round last month and this week announced the first commercial application of its Intraspect pain-relief procedure. In this podcast, Hykes doles out some valuable career advice for wanna be CEOs and talks about the technology that could turn Relievant into a Medtech powerhouse.